PharmaShots | Incisive News in 3 Shots

Subscribe Now

Ilumetri

Almirall's Ilumetri (tildrakizumab) Receives NICE's Provisional Approval for Moderate-To-Severe Plaque Psoriasis

Almirall's Ilumetri (tildrakizumab) Receives NICE's Provisional Approval for Moderate-To-Severe Plaque Psoriasis

March 11, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us